中航科工(02357.HK)擬購航宇救生及西安制動全部股權
中航科工(02357.HK)公布,與控股股東中國航空工業、中航機載系統和西飛資產簽訂了股權轉讓框架協議。根據框架協議,中國航空工業、中航機載系統及西飛資產擬向集團出售其持有的航宇救生及西安制動100%之股權。
航宇救生主要從事航空彈射救生、飛機乘員個體防護、空降空投等專業領域裝備的研製。目前航宇救生是中航機載系統的全資附屬公司。西安制動主要從事航空機輪、煞車系統、煞車材料及航空液壓、氣動產品研發和生產。目前西安制動是西飛資產的全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.